Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamivudine in Individuals With Rett Syndrome: Clinical, Biochemical, and Cellular Evaluation

NCT07640503 is registered in ClinicalTrials.gov with Maria Denise Fernandes Carvalho de Andrade as lead sponsor.

NCT NCT07640503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07640503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamivudine in Individuals With Rett Syndrome: Clinical, Biochemical, and Cellular Evaluation
Lead sponsor
Maria Denise Fernandes Carvalho de Andrade
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
November 5, 2025
Completion date
December 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rett syndrome